{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T11:14:28Z","timestamp":1726485268199},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1097\/tp.0000000000001312","type":"journal-article","created":{"date-parts":[[2016,7,28]],"date-time":"2016-07-28T00:03:42Z","timestamp":1469664222000},"page":"2016-2017","source":"Crossref","is-referenced-by-count":1,"title":["Decreased Circulating Sclerostin Levels in Renal Transplant Recipients With Persistent Hyperparathyroidism"],"prefix":"10.1097","volume":"100","author":[{"given":"Grahame J.","family":"Elder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-4-20210211","doi-asserted-by":"crossref","first-page":"19883","DOI":"10.1074\/jbc.M413274200","article-title":"Sclerostin binds to LRP5\/6 and antagonizes canonical Wnt signaling","volume":"280","author":"Li","year":"2005","journal-title":"J Biol Chem"},{"key":"R2-4-20210211","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1084\/jem.20031454","article-title":"Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist","volume":"199","author":"van Bezooijen","year":"2004","journal-title":"J Exp Med"},{"key":"R3-4-20210211","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1002\/jbmr.345","article-title":"Sclerostin is a locally acting regulator of late-osteoblast\/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanism","volume":"26","author":"Atkins","year":"2011","journal-title":"J Bone Miner Res"},{"key":"R4-4-20210211","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1002\/jbmr.1718","article-title":"High serum sclerostin predicts the occurrence of osteoporotic fractures in postmenopausal women: the Center of Excellence for Osteoporosis Research Study","volume":"27","author":"Ardawi","year":"2012","journal-title":"J Bone Miner Res"},{"key":"R5-4-20210211","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1210\/jc.2011-3419","article-title":"Serum sclerostin and risk of hip fracture in older Caucasian women","volume":"97","author":"Arasu","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"R6-4-20210211","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1210\/en.2005-0239","article-title":"Chronic elevation of PTH in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis","volume":"146","author":"Bellido","year":"2005","journal-title":"Endocrinology"},{"key":"R7-4-20210211","doi-asserted-by":"crossref","first-page":"E1848","DOI":"10.1210\/jc.2011-1534","article-title":"Acute decline in serum sclerostin in response to PTH infusion in healthy men","volume":"96","author":"Yu","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"R8-4-20210211","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.coph.2005.07.004","article-title":"Parathyroid hormone\u2014a bone anabolic and catabolic agent","volume":"5","author":"Poole","year":"2005","journal-title":"Curr Opin Pharmacol"},{"key":"R9-4-20210211","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/ki.2015.156","article-title":"Sclerostin and DKK1: new players in renal bone and vascular disease","volume":"88","author":"Evenepoel","year":"2015","journal-title":"Kidney Int"},{"key":"R10-4-20210211","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2215\/CJN.06550810","article-title":"Sclerostin and Dickkopf-1 in renal osteodystrophy","volume":"6","author":"Cejka","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"R11-4-20210211","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1210\/jc.2013-2786","article-title":"Renal elimination of sclerostin increases with declining kidney function","volume":"99","author":"Cejka","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"R12-4-20210211","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/1471-2369-14-219","article-title":"Relationship between sclerostin and cardiovascular calcification in hemodialysis patients: a cross-sectional study","volume":"14","author":"Brandenburg","year":"2013","journal-title":"BMC Nephrol"},{"key":"R13-4-20210211","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bone.2009.09.006","article-title":"High phosphorus diet induces vascular calcification, a related decrease in bone mass and changes in the aortic gene expression","volume":"46","author":"Roman-Garcia","year":"2010","journal-title":"Bone"},{"key":"R14-4-20210211","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1097\/TP.0000000000001311","article-title":"Decreased circulating sclerostin levels in renal transplant recipients with persistent hyperparathyroidism","volume":"100","author":"Evenepoel","year":"2016","journal-title":"Transplantation"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000001312","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T07:24:37Z","timestamp":1620977077000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201610000-00004"}},"subtitle":["Who's Conducting the Orchestra?"],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":14,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000001312","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]}}}